Mammographic Screening: No Reliable Supporting Evidence?
Overview
Authors
Affiliations
Much confusion is being generated by the conclusion of a recent review that "there is no reliable evidence that screening for breast cancer reduces mortality." In that review, however, there was no appreciation of the appropriate mortality-related measure of screening's usefulness; and correspondingly, there was no estimation of the magnitude of this measure. We take this measure to be the proportional reduction in case-fatality rate, and studied its magnitude on the basis of the only valid and otherwise suitable trial. We found reliable evidence of fatality reduction, apparently substantial in magnitude.
Mammograms and Mortality: How Has the Evidence Evolved?.
Kowalski A J Econ Perspect. 2021; 35(2):119-140.
PMID: 34421215 PMC: 8371936. DOI: 10.1257/jep.35.2.119.
Henschke C, Yip R, Shaham D, Zulueta J, Aguayo S, Reeves A J Thorac Imaging. 2020; 36(1):6-23.
PMID: 32520848 PMC: 7771636. DOI: 10.1097/RTI.0000000000000538.
Mortality reductions due to mammography screening: Contemporary population-based data.
Hanley J, Hannigan A, OBrien K PLoS One. 2017; 12(12):e0188947.
PMID: 29261685 PMC: 5737972. DOI: 10.1371/journal.pone.0188947.
Lung cancer: Low-dose CT screening - determining the right interval.
Yankelevitz D, Henschke C Nat Rev Clin Oncol. 2016; 13(9):533-4.
PMID: 27402578 DOI: 10.1038/nrclinonc.2016.106.
The importance of the regimen of screening in maximizing the benefit and minimizing the harms.
Henschke C, Li K, Yip R, Salvatore M, Yankelevitz D Ann Transl Med. 2016; 4(8):153.
PMID: 27195271 PMC: 4860488. DOI: 10.21037/atm.2016.04.06.